Fundraising for Bristol Myers Squibb’s C2C4C cycling events opens, they expand to support UICC members in Asia-Pacific

The annual cycling events organised by UICC partner Bristol Myers Squibb’s, known as ‘C2C4C’, return once again this year to support UICC organisations. C2C4C – short for Country 2 Country 4 Cancer in Europe and Continent 2 Continent 4 Cancer in Japan and Latin America – brings together employees from around the world to raise funds for UICC member organisations. This year, for the first time, the Japan ride will also support UICC members in the Asia-Pacific region.

Fundraising has now opened for the European event, which begins 5 September in Munich and concludes 22 September in London. Ninety-six employees from 19 countries will take part, each riding approximately 360 kilometres over three days. Bristol Myers Squibb has committed to match donations up to USD 200,000 in support of cancer organisations across the region.

“The C2C4C ride unites us, fostering teamwork in honor of our friends, family, and the countless cancer patients we strive to support daily through our work. I am deeply moved by the significance of this initiative to all of us. I had the honour to ride the C2C4C last year in Latin America and live this unforgettable experience. This year, I will be supporting my colleagues from the European teams and contribute to raising funds for UICC's members to ensure patients receive the diagnosis, treatment, and care necessary to fight cancer.”
– Emma Charles, Senior Vice President, Europe Region, Bristol Myers Squibb

In Japan, 60 Bristol Myers Squibb employees representing six countries – including India and Singapore, both new to the initiative – will cycle nearly 1,800 kilometres from Tokyo Bay to Otemachi between 7–21 October. The company will provide up to USD 50,000 in matched funding for donations raised, which will support UICC member organisations in the Asia-Pacific region.

Latin America’s ride returns for its third year from 1–9 December. 45 employees from seven countries will cover roughly 900 kilometres between Pucón and Puerto Varas, Chile. Bristol Myers Squibb will also be matching donations up to USD 50,000 will go toward supporting UICC member organisations in the region.

“As the C2C4C initiative enters a new chapter with its expansion into Asia, we are reminded of the global spirit that drives these events. The energy and dedication of the participants embody the kind of collaboration and shared purpose that are essential to advancing people-centred cancer care. On behalf of UICC’s members, I thank Bristol Myers Squibb for their unwavering commitment and continued partnership in this shared mission.”
– Cary Adams, CEO of UICC

C2C4C began in the United States in 2014 and has since raised over USD 19 million globally. It is not a race, but a commitment by participants – many of whom are novice cyclists – to train for months and ride in solidarity with those affected by cancer.

Learn more about the 2025 C2C4C European ride and donate